weight loss drug news today glp-1 october 2025 drugs leave users low on key nutrients, study finds How do weight-loss drugs work?
Description
GLP-1 therapy is generally recommended for individuals diagnosed with type 2 diabetes who require additional glycemic control, patients with a body mass index (BMI) greater than 27, especially those with weight-related comorbidities, and those not achieving target blood glucose levels with metformin or other oral hypoglycemic agents

All of these characteristics make it perfect for the dieting male or female, but more importantly, it is a clinically proven bio availability enhancer for nutrients

Evidence-based lifestyle interventionsincluding structured dietary advice, physical activity programmes, and psychological supportshould be explored as first-line approaches

Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)

StatNews reports that the tariffs would likely affect about $12 billion of the $274 billion in pharmaceuticals imported into the US annually, which would limit the impact of these tariffs on employer-sponsored health plans

Endocrinology (1962) 70:63849
